| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |